Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CBIO

Crescent Biopharma Inc

May 29 • 04:00PM ET

20.65

-0.82 -3.82 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: INCY BMRN VKTX KRYS KYMR NUVL RYTM AXSM MDGL NBIX

| Held by: VTI VXF AVSC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-12.48	Insider Own	21.45%	Shs Outstand	27.57M	Perf Week	2.08%
Market Cap	569.36M	Forward P/E	-	EPS next Y	-3.25	Insider Trans	29.86%	Shs Float	21.66M	Perf Month	-1.38%
Enterprise Value	385.74M	PEG	-	EPS next Q	-0.78	Inst Own	78.98%	Short Float	13.39%	Perf Quarter	70.80%
Income	-162.08M	P/S	47.93	EPS this Y	75.02%	Inst Trans	7.85%	Short Ratio	11.07	Perf Half Y	47.50%
Sales	11.88M	P/B	3.17	EPS next Y	-1.49%	ROA	-158.03%	Short Interest	2.90M	Perf YTD	74.11%
Book/sh	6.52	P/C	3.01	EPS next 5Y	35.34%	ROE	-173.14%	52W High	27.41 -24.66%	Perf Year	-3.14%
Cash/sh	6.86	P/FCF	-	EPS past 3/5Y	45.01% 33.26%	ROIC	-87.64%	52W Low	8.72 136.81%	Perf 3Y	-88.84%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	424.86% 1.31%	Gross Margin	98.75%	Volatility	10.50% 12.54%	Perf 5Y	-91.90%
Dividend TTM	-	EV/Sales	32.47	EPS Y/Y TTM	72.70%	Oper. Margin	-1372.85%	ATR (14)	2.15	Perf 10Y	-97.56%
Dividend Ex-Date	-	Quick Ratio	13.78	Sales Y/Y TTM	-100.00%	Profit Margin	-1363.94%	RSI (14)	53.81	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	13.78	EPS Q/Q	78.91%	SMA20	6.76%	Beta	1.17	Target Price	29.50
Payout	-	Debt/Eq	0.01	Sales Q/Q	-	SMA50	8.40%	Rel Volume	1.60	Prev Close	21.47
Employees	44	LT Debt/Eq	0.01	Earnings	Apr 29 AMC	SMA200	47.35%	Avg Volume	262.12K	Price	20.65
IPO	Jan 10, 2014	Option/Short	No / Yes	EPS/Sales Surpr.	20.33% 180.03%	Trades		Volume	419,765	Change	-3.82%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)